Concanamycin A
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Concanamycin A
Description:
Concanamycin A (Folimycin; Antibiotic X 4357B) is a macrolide antibiotic, a vacuolar type H+-ATPase (V-ATPase) inhibitor. Concanamycin A is also an inhibitor of lysosomal acidification, can be used to T cell-mediated inflammation research[1]-[5].Product Name Alternative:
Antibiotic X 4357B; Folimycin; X 4357BUNSPSC:
12352005Hazard Statement:
H300, H310, H319, H330Target:
Antibiotic; Bacterial; Proton PumpType:
Natural ProductsRelated Pathways:
Anti-infection; Membrane Transporter/Ion ChannelApplications:
Cancer-programmed cell deathField of Research:
Cancer; Infection; Inflammation/ImmunologyAssay Protocol:
https://www.medchemexpress.com/concanamycin-a.htmlPurity:
99.84Solubility:
DMSO : ≥ 10 mg/mLSmiles:
C[C@H]([C@@](C[C@H]1O[C@@](O[C@H](C)[C@H]2OC(N)=O)([H])C[C@H]2O)(O[C@H](/C=C/C)[C@H]1C)O)[C@H](O)[C@@H]([C@](OC(/C(OC)=C/C(C)=C/[C@H]([C@@H](O)[C@H]3CC)C)=O)([H])[C@H](/C=C/C=C(C[C@H]([C@@H]3O)C)/C)OC)CMolecular Formula:
C46H75NO14Molecular Weight:
866.09Precautions:
H300, H310, H319, H330References & Citations:
[1]Togashi K, et al. Concanamycin A, a vacuolar type H (+) -ATPase inhibitor, induces cell death in activated CD8 (+) CTL. Cytotechnology. 1997 Nov;25 (1-3) :127-35.|[2]Eswarappa SM, et al. Folimycin (concanamycin A) inhibits LPS-induced nitric oxide production and reduces surface localization of TLR4 in murine macrophages. Innate Immun. 2008 Feb;14 (1) :13-24.|[3]Hines IN, et al. Impaired T cell-mediated hepatitis in peroxisome proliferator activated receptor alpha (PPARα) -deficient mice. Biol Res. 2018 Feb 15;51 (1) :5.|[4]Woo JT, et al. Isolation, characterization and biological activities of concanamycins as inhibitors of lysosomal acidification. J Antibiot (Tokyo) . 1992 Jul;45 (7) :1108-16.|[5]Vaněk, Z., et al. Immunomodulators isolated from microorganisms. Folia Microbiol. 1991. 36:99–111.Shipping Conditions:
Blue IceStorage Conditions:
-20°C, 3 years (Powder)Scientific Category:
Natural ProductsClinical Information:
No Development ReportedIsoform:
MacrolideCAS Number:
[80890-47-7]
